Regulators have been clamping down on Ant Group, even cancelling its expected $35 billion twin IPO late last year.Business, Policy & Regulation, News, China, Regulation, Jack Ma, Ant GroupRead More

You might also be interested in reading House GOP reportedly aiming for Medicaid expansion reforms.